Organon & Co. — Investor Relations & Filings
Filings indexed
399
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
OGN
Organon & Co. is a global healthcare company dedicated to improving the health of women. The company's portfolio is structured around three core pillars: Women's Health, Biosimilars, and Established Brands. The Women's Health division focuses on reproductive health, including contraception and fertility, as well as other conditions unique to women. The Biosimilars business aims to provide more accessible treatment options, particularly in oncology and immunology. The Established Brands unit manages a diverse range of therapies for conditions such as cardiovascular disease, respiratory illnesses, dermatology, and neurology. Organon's portfolio includes more than 70 medicines and devices, which are available in over 140 markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM SD | 2026-05-29 | English | |
| 10-Q - Organon & Co. (0001821825) (Filer) | 2026-05-04 | English | |
| 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-30 | English | |
| 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-27 | English | |
| 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | |
| 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47882447 | FORM SD | 2026-05-29 | English | ||
| 40904289 | 10-Q - Organon & Co. (0001821825) (Filer) | 2026-05-04 | English | ||
| 39076594 | 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-30 | English | ||
| 37390208 | 8-K - Organon & Co. (0001821825) (Filer) | 2026-04-27 | English | ||
| 32899042 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899043 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899041 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899046 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899044 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899047 | 4 - ORGANON & CO. (0001821825) (Filer) | 2026-03-03 | English | ||
| 32899053 | 10-K - ORGANON & CO. (0001821825) (Filer) | 2026-02-24 | English | ||
| 32899049 | 8-K - ORGANON & CO. (0001821825) (Filer) | 2026-02-20 | English | ||
| 31899172 | 8-K Filing | 2026-02-12 | English | ||
| 13296055 | FORM 4/A | 2026-01-16 | English | ||
|
2025
1 filing
| |||||
| 13296058 | FORM 4 | 2025-11-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
Organon & Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31461/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31461 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31461 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31461 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31461}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Organon & Co. (id: 31461)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.